Kiyatec Inc.

Kiyatec Inc. , based in the US, specializes in innovative cancer care solutions through its 3D Predict platform, enabling personalized treatment predictions to enhance oncological decisions. Founded in 2010 in Greenville, US, Kiyatec Inc. focuses on developing advanced oncology solutions.

The company received its latest funding round, a Series C, led by Bruker Corporation, with a total amount raised of USD 18. 060 mn. The firm has completed 8 total deals, with the most recent deal occurring on May 18, 2023. CEO Matt Gevaert, a key figure in the company's trajectory, has been instrumental in its development and growth.

Kiyatec's core offerings center around its innovative 3D Predict platform, designed to revolutionize cancer care by providing patient-specific predictions of response to drug therapies prior to treatment. Utilizing advanced 3D cell culture technology, it simulates tumor behavior in response to therapeutic agents, allowing oncologists to tailor treatment plans effectively. Kiyatec serves healthcare professionals and pharmaceutical companies, primarily within the United States and select international markets, collaborating with leading cancer institutions and biopharmaceutical partners. Kiyatec operates on a B2B revenue model, partnering with healthcare providers and pharmaceutical companies to offer its 3D Predict platform and related services.

This model includes subscription agreements for ongoing platform use, as well as collaborative partnerships for clinical research and product development. The pricing structures include tiered subscription plans tailored to meet the needs of various healthcare institutions and pharmaceutical partners, fostering long-term relationships and ongoing value delivery. In May 2023, Kiyatec Inc. raised USD 18.

060 mn in a Series C funding round, which will be utilized to support product commercialization and platform development. The company aims to expand its market reach by targeting new geographic regions, with specific plans for further penetration into Europe and Asia by the end of 2024. Additionally, Kiyatec is focused on the development of new features for the 3D Predict platform to enhance its capabilities and user experience.